Aterian, Inc. (NASDAQ:ATER ) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Ilya Grozovsky - Vice President, IR & Corporate Development Joseph Risico - Co-CEO Arturo Rodriguez - Co-CEO & CFO Conference Call Participants Brian Kinstlinger - Alliance Global Partners Marvin Fong - BTIG Operator Thank you for standing by. My name is Alex, and I will be your conference ...
First Quarter Net Loss Improved by 80.0% Year Over Year and Adjusted EBITDA Loss Improved by 38.4% Affirms Second Half 2024 Adjusted EBITDA Profitability Target NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the first quarter ended March 31, 2024. First Quarter Highlights First quarter 2024 net revenue declined 4...
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian”) announced today that it plans to report its first quarter 2024 financial results after the market close on Tuesday, May 7, 2024, and plans to host a conference call for investors and interested parties at 5:00 p.m. ET that evening.
First Quarter Net Revenue Range Improved to $20.0 Million to $21.0 Million First Quarter Adjusted EBITDA Loss Range Improved to ($2.4) Million to ($2.9) Million NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced updates to its previously announced net revenue and Adjusted EBITDA ranges for the first quarter of 2024 ended March...
Expected to Start Trading on a Split-adjusted Basis Beginning March 22, 2024 Expected to Start Trading on a Split-adjusted Basis Beginning March 22, 2024
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Highlights Fourth quarter 2023 net revenue declined 40.3% to $32.8 million, compared to $54.9 million in the fourth quarter of 2022.
NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today announced the recent closing of a strategic minority equity investment in 4th & Heart, the leading U.S. maker of premium ghee butter products. The Company invested approximately $0.2 million in cash and approximately 145,000 shares of Aterian common stock.
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.